Axsome Therapeutics, Inc. (AXSM) stock
AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$134.00−1.95 (-1.43%)
Close on Nov 18, 2026Market cap $7.02BP/E –Yield –
Axsome Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Axsome Therapeutics's EV/EBITDA was 4.0× on Jul 31, 2018, against 2.6× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Jul 31, 2018 | 4.0× | +0.1 |
| 2017 | Dec 29, 2017 | 3.9× | −0.2 |
| 2016 | Dec 30, 2016 | 4.1× | – |
See a number that looks wrong?